Bausch & Lomb Corp (BLCO) Financial Statements (2026 and earlier)

Company Profile

Business Address 520 APPLEWOOD CRESCENT
VAUGHAN, ON L4K 4B4
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3851 - Ophthalmic Goods (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments305331354
Cash and cash equivalent305331354
Restricted cash and investments11326
Receivables1,026839724
Inventory, net of allowances, customer advances and progress billings1,0361,028628
Inventory1,0361,028628
Other undisclosed current assets410541405
Total current assets:2,7882,7422,137
Noncurrent Assets
Property, plant and equipment1,4851,3901,300
Intangible assets, net (including goodwill)8,0178,1646,565
Goodwill4,5234,5754,507
Intangible assets, net (excluding goodwill)3,4943,5892,058
Deferred income tax assets885921927
Other noncurrent assets294225215
Total noncurrent assets:10,68110,7009,007
TOTAL ASSETS:13,46913,44211,144
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,6981,5491,271
Accounts payable389522370
Accrued liabilities1,3091,027901
Debt403025
Total current liabilities:1,7381,5791,296
Noncurrent Liabilities
Long-term debt and lease obligation4,7444,5322,411
Long-term debt, excluding current maturities4,7444,5322,411
Liabilities, other than long-term debt443411336
Deferred income tax liabilities13147
Other liabilities430397329
Total noncurrent liabilities:5,1874,9432,747
Total liabilities:6,9256,5224,043
Equity
Equity, attributable to parent6,4736,8507,033
Additional paid in capital8,4298,3498,285
Accumulated other comprehensive loss(1,385)(1,245)(1,258)
Retained earnings (accumulated deficit)(571)(254)6
Equity, attributable to noncontrolling interest717068
Total equity:6,5446,9207,101
TOTAL LIABILITIES AND EQUITY:13,46913,44211,144

Income Statement (P&L) ($ in millions)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
Revenues4,7914,1463,768
Cost of revenue(2,204)(1,956)(1,776)
Gross profit:2,5872,1901,992
Operating expenses(2,425)(2,060)(1,785)
Other operating expense, net(44)(74)(13)
Other undisclosed operating income447413
Operating income:162130207
Nonoperating income (expense)3(13)12
Investment income, nonoperating15156
Gain (loss), foreign currency transaction, before tax(12)(28)6
Interest and debt expense(399)(283)(146)
Income (loss) from continuing operations before income taxes:(234)(166)73
Income tax expense (benefit)(71)(82)(58)
Net income (loss):(305)(248)15
Net loss attributable to noncontrolling interest(12)(12)(9)
Net income (loss) available to common stockholders, diluted:(317)(260)6

Comprehensive Income ($ in millions)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
Net income (loss):(305)(248)15
Other comprehensive income (loss)(141)12(226)
Comprehensive loss:(446)(236)(211)
Comprehensive loss, net of tax, attributable to noncontrolling interest(11)(11)(6)
Comprehensive loss, net of tax, attributable to parent:(457)(247)(217)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: